T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.01B |
| 2 |
Broadcom
AVGO
|
+$1.49B |
| 3 |
GE Vernova
GEV
|
+$1.19B |
| 4 |
International Paper
IP
|
+$1.05B |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$952M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.31B |
| 2 |
Constellation Energy
CEG
|
+$1.94B |
| 3 |
Qualcomm
QCOM
|
+$1.74B |
| 4 |
NVIDIA
NVDA
|
+$1.71B |
| 5 |
Salesforce
CRM
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.98% |
| 2 | Healthcare | 14.89% |
| 3 | Financials | 10.35% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Communication Services | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
Personalis
PSNL
$1.52B
| $112K | ﹤0.01% |
95,000
| – | – |
|
2727
Rayonier Advanced Materials
RYAM
$577M
| $112K | ﹤0.01% |
20,418
+3,487
| +21% | +$17K |
|
|
TSVT
2728
DELISTED
2seventy bio
TSVT
| $112K | ﹤0.01% |
28,929
| – | – |
|
2729
Advantage Solutions
ADV
$419M
| $111K | ﹤0.01% |
1,369
+369
| +37% | +$34.3K |
|
2730
BRC Inc
BRCC
$211M
| $111K | ﹤0.01% |
17,869
+4,948
| +38% | +$25.7K |
|
2731
Entravision Communication
EVC
$855M
| $111K | ﹤0.01% |
54,431
+5,961
| +12% | +$12.3K |
|
2732
Westrock Coffee
WEST
$828M
| $111K | ﹤0.01% |
+10,830
| New | +$111K |
|
2733
Cardiff Oncology
CRDF
$79.4M
| $110K | ﹤0.01% |
49,237
+12,737
| +35% | +$48K |
|
|
SUP
2734
DELISTED
Superior Industries International
SUP
| $110K | ﹤0.01% |
33,700
| – | – |
|
2735
Upland Software
UPLD
$17.9M
| $110K | ﹤0.01% |
4,400
| – | – |
|
|
FFWM
2736
DELISTED
First Foundation Inc
FFWM
| $108K | ﹤0.01% |
16,401
+1,635
| +11% | +$10K |
|
2737
Lindblad Expeditions
LIND
$2.25B
| $108K | ﹤0.01% |
11,131
+1,014
| +10% | +$7.86K |
|
2738
Clarus
CLAR
$144M
| $107K | ﹤0.01% |
15,751
+2,009
| +15% | +$13.3K |
|
2739
Evolv Technologies
EVLV
$1.03B
| $107K | ﹤0.01% |
41,784
+8,971
| +27% | +$29.7K |
|
2740
Granite Ridge Resources
GRNT
$660M
| $107K | ﹤0.01% |
+16,840
| New | +$109K |
|
2741
Liberty Latin America Class A
LILA
$1.67B
| $107K | ﹤0.01% |
+16,311
| New | +$90.9K |
|
|
RPC
2742
Ridgepost Capital
RPC
$978M
| $107K | ﹤0.01% |
12,608
| – | – |
|
2743
Amylyx Pharmaceuticals
AMLX
$2.58B
| $106K | ﹤0.01% |
55,600
-914,955
| -94% | -$1.77M |
|
|
EWCZ
2744
DELISTED
European Wax Center
EWCZ
| $106K | ﹤0.01% |
+10,668
| New | +$121K |
|
2745
uniQure
QURE
$3.18B
| $105K | ﹤0.01% |
23,300
+7,200
| +45% | +$35.1K |
|
2746
Treace Medical Concepts
TMCI
$302M
| $104K | ﹤0.01% |
15,604
+2,632
| +20% | +$21.3K |
|
2747
American Well
AMWL
$218M
| $102K | ﹤0.01% |
15,905
+1,439
| +10% | +$14.5K |
|
|
SLRN
2748
DELISTED
ACELYRIN
SLRN
| $102K | ﹤0.01% |
22,944
+2,241
| +11% | +$10.5K |
|
2749
Nkarta
NKTX
$170M
| $101K | ﹤0.01% |
+16,928
| New | +$120K |
|
|
FNA
2750
DELISTED
Paragon 28, Inc.
FNA
| $100K | ﹤0.01% |
14,566
+1,944
| +15% | +$16.4K |
|
Similar funds
T. Rowe Price Associates's Q2 2024 Portfolio in Review
As of Q2 2024, T. Rowe Price Associates held 3,089 positions worth $836B, up 2.4% from $816B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
T. Rowe Price Associates's Q2 2024 filing shows 135 new, 1,850 increased, 836 reduced and 113 closed positions. Its largest new stake was Tempus AI: 5,227,120 shares worth $183M. The largest sale was Microsoft, an estimated $2.31B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2024 buy was Tempus AI: 5,227,120 shares worth $183M.
- T. Rowe Price Associates added most to Apple in Q2 2024, an estimated $4.01B increase.
- T. Rowe Price Associates's biggest Q2 2024 reduction was Microsoft, cutting an estimated $2.31B.
- T. Rowe Price Associates fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $570M.
- T. Rowe Price Associates's ten largest holdings make up 36% of its $836B portfolio in Q2 2024.
- T. Rowe Price Associates opened 135 new positions and closed 113 in Q2 2024.
- T. Rowe Price Associates's portfolio value rose 2.4% quarter-over-quarter to $836B.
Based on T. Rowe Price Associates's 13F filing for Q2 2024, filed 14 Aug 2024.